Ambicka, A.; Grela-Wojewoda, A.; Niemiec, J.; Mularz, K.; Harazin-Lechowska, A.; Ryś, J.; Adamczyk, A.
Prognostic Significance of Selected Tumor Stroma Parameters in Patients with HER2-Positive Breast Cancer Treated with Adjuvant Trastuzumab. Cancers 2026, 18, 1243.
https://doi.org/10.3390/cancers18081243
AMA Style
Ambicka A, Grela-Wojewoda A, Niemiec J, Mularz K, Harazin-Lechowska A, Ryś J, Adamczyk A.
Prognostic Significance of Selected Tumor Stroma Parameters in Patients with HER2-Positive Breast Cancer Treated with Adjuvant Trastuzumab. Cancers. 2026; 18(8):1243.
https://doi.org/10.3390/cancers18081243
Chicago/Turabian Style
Ambicka, Aleksandra, Aleksandra Grela-Wojewoda, Joanna Niemiec, Katarzyna Mularz, Agnieszka Harazin-Lechowska, Janusz Ryś, and Agnieszka Adamczyk.
2026. "Prognostic Significance of Selected Tumor Stroma Parameters in Patients with HER2-Positive Breast Cancer Treated with Adjuvant Trastuzumab" Cancers 18, no. 8: 1243.
https://doi.org/10.3390/cancers18081243
APA Style
Ambicka, A., Grela-Wojewoda, A., Niemiec, J., Mularz, K., Harazin-Lechowska, A., Ryś, J., & Adamczyk, A.
(2026). Prognostic Significance of Selected Tumor Stroma Parameters in Patients with HER2-Positive Breast Cancer Treated with Adjuvant Trastuzumab. Cancers, 18(8), 1243.
https://doi.org/10.3390/cancers18081243
